TYROSINE KINASE INHIBITOR
Clinical trials for TYROSINE KINASE INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new TYROSINE KINASE INHIBITOR trials appear
Sign up with your email to follow new studies for TYROSINE KINASE INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for Hard-to-Treat lung cancer
Disease control CompletedThis study tested a combination of two drugs—bevacizumab and a higher dose of icotinib—in 35 people with advanced non-squamous lung cancer that has a specific genetic change (EGFR L858R). The goal was to see if this combo could delay cancer growth better than standard treatment. …
Matched conditions: TYROSINE KINASE INHIBITOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Liver cancer patients: do pre-transplant drugs improve outcomes?
Knowledge-focused CompletedThis study looked back at data from 484 liver cancer patients who had a liver transplant to see if taking certain cancer drugs (tyrosine kinase inhibitors) before the transplant helped them live longer or kept the cancer from coming back. The researchers checked survival rates, c…
Matched conditions: TYROSINE KINASE INHIBITOR
Sponsor: Hu Liangshuo • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC